ORLOFF JOHN J (EVP, Research & Development) reported 1 transaction at ALEXION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/9/2021ACC: 0000899866-21-000050
Officer· EVP, Research & Development
Since Feb 2019
-1.96K
Net shares
Net seller
$346.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.96K disposed
Non-Derivative Transactions1
Common Stock, par value $.0001 per share
Direct
Shares
−1.96K
Price / share
$177.00
Trade value
$346.39K
% of position
2.2%
6/8/2021
88.32K→86.37K
Total
Net shares
−1.96K
Net value
-$346.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 6/8/2021 | F · Tax Withholding | −1.96K | $177.00 | $346.39K | 2.2% | 88.32K | 86.37K |
| Total | −1.96K | -$346.39K | ||||||
Derivative Transactions0
No derivative transactions reported